HomeCompareAURWF vs JNJ

AURWF vs JNJ: Dividend Comparison 2026

AURWF yields 71428.57% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AURWF wins by $1.6804617092236922e+25M in total portfolio value
10 years
AURWF
AURWF
● Live price
71428.57%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.6804617092236922e+25M
Annual income
$16,758,464,082,723,930,000,000,000,000,000.00
Full AURWF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — AURWF vs JNJ

📍 AURWF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAURWFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AURWF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AURWF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AURWF
Annual income on $10K today (after 15% tax)
$6,071,428.57/yr
After 10yr DRIP, annual income (after tax)
$14,244,694,470,315,339,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, AURWF beats the other by $14,244,694,470,315,339,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AURWF + JNJ for your $10,000?

AURWF: 50%JNJ: 50%
100% JNJ50/50100% AURWF
Portfolio after 10yr
$8.402308546118461e+24M
Annual income
$8,379,232,041,361,964,000,000,000,000,000.00/yr
Blended yield
99.73%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

AURWF
No analyst data
Altman Z
-14.7
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AURWF buys
0
JNJ buys
0
No recent congressional trades found for AURWF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAURWFJNJ
Forward yield71428.57%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$1.6804617092236922e+25M$30.3K
Annual income after 10y$16,758,464,082,723,930,000,000,000,000,000.00$4,689.40
Total dividends collected$1.6801590475897682e+25M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AURWF vs JNJ ($10,000, DRIP)

YearAURWF PortfolioAURWF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$7,153,557$7,142,857.14$10,592$272.30+$7.14MAURWF
2$4,783,059,608$4,775,405,302.31$11,289$357.73+$4783.05MAURWF
3$2,989,196,089,253$2,984,078,215,471.53$12,123$472.89+$2989196.08MAURWF
4$1,746,108,740,720,723$1,742,910,300,905,223.00$13,141$629.86+$1746108740.71MAURWF
5$953,366,906,359,837,700$951,498,570,007,266,600.00$14,408$846.81+$953366906359.82MAURWF
6$486,546,837,026,708,500,000$485,526,734,436,903,500,000.00$16,021$1,151.60+$486546837026708.50MAURWF
7$232,096,820,383,666,640,000,000$231,576,215,268,048,070,000,000.00$18,122$1,588.22+$232096820383666624.00MAURWF
8$103,489,940,016,498,150,000,000,000$103,241,596,418,687,620,000,000,000.00$20,930$2,228.20+$103489940016498147328.00MAURWF
9$43,133,653,750,454,530,000,000,000,000$43,022,919,514,636,880,000,000,000,000.00$24,792$3,191.91+$4.313365375045453e+22MAURWF
10$16,804,617,092,236,920,000,000,000,000,000$16,758,464,082,723,930,000,000,000,000,000.00$30,274$4,689.40+$1.6804617092236922e+25MAURWF

AURWF vs JNJ: Complete Analysis 2026

AURWFStock

Aurwest Resources Corporation, a junior resource company, engages in the acquisition, exploration, and evaluation of mineral properties in North America. The company primarily explores for gold and copper deposits. It holds 100% interests in the Stellar Copper-Gold Project covering an area of 24,533 ha located in British Columbia; and Stars copper porphyry project, consisting of four mineral tenures that covers an area of 3,761ha. The company also has option agreements to acquire 100% interest in the Paradise Lake, Miguels Lake, and the Stony Caldera gold properties covering an area of 47,800 hectares in Central Newfoundland. The company was formerly known as Shamrock Enterprises Inc. and changed its name to Aurwest Resources Corporation in January 2020. Aurwest Resources Corporation was incorporated in 2008 and is headquartered in Calgary, Canada.

Full AURWF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this AURWF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AURWF vs SCHDAURWF vs JEPIAURWF vs OAURWF vs KOAURWF vs MAINAURWF vs ABBVAURWF vs MRKAURWF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.